Viewing Study NCT04032457


Ignite Creation Date: 2025-12-24 @ 6:32 PM
Ignite Modification Date: 2026-02-17 @ 4:50 PM
Study NCT ID: NCT04032457
Status: COMPLETED
Last Update Posted: 2020-10-06
First Post: 2019-04-17
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: PAVES Benchmarking Pilot Study of Daily Disposable Contact Lenses
Sponsor: Vision Service Plan
Organization:

Study Overview

Official Title: PAVES Benchmarking Pilot Study of Daily Disposable Contact Lenses
Status: COMPLETED
Status Verified Date: 2020-10
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: PAVES
Brief Summary: The study will compare the short-term clinical performance and wearer and practitioner acceptability in a pilot study of a new-to-market spherical silicone hydrogel daily disposable soft contact lens (SiHyDD) to three (3) benchmark soft daily disposable lenses (DD) and, subsequently, of a new-to-market hydrogel spherical daily disposable (HydDD) soft contact lens to three (3) other hydrogel daily disposable lenses. .

The primary outcome variables for this study are subjective comfort and lens preference.
Detailed Description: The objective of the study is to compare the short-term clinical performance and wearer and practitioner acceptability in a pilot study of a new-to-market spherical silicone hydrogel olifilcon B with Tangible Coating daily disposable soft contact lens (SiHyDD) to three (3) benchmark soft daily disposable lenses (DD) and, subsequently, of a new-to-market hydrogel etafilcon A with Tangible Coating spherical daily disposable (HydDD) soft contact lens to three (3) other hydrogel daily disposable lenses. .

The primary outcome variables for this study are subjective comfort and lens preference.

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: True
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: False
Is an FDA AA801 Violation?: